Pharmadrug (XCNQ:PHRX) COGS-to-Revenue : 0.00 (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Pharmadrug COGS-to-Revenue?

Pharmadrug's Cost of Goods Sold for the three months ended in Dec. 2023 was C$0.00 Mil. Its Revenue for the three months ended in Dec. 2023 was C$0.00 Mil.

Pharmadrug's COGS to Revenue for the three months ended in Dec. 2023 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Pharmadrug's Gross Margin % for the three months ended in Dec. 2023 was N/A%.

Pharmadrug COGS-to-Revenue Historical Data

The historical data trend for Pharmadrug's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmadrug COGS-to-Revenue Chart

Pharmadrug Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.59

0.73

1.29

Pharmadrug Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Pharmadrug COGS-to-Revenue Calculation

Pharmadrug's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Pharmadrug's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Pharmadrug (XCNQ:PHRX) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Pharmadrug's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Pharmadrug COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Pharmadrug's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmadrug (XCNQ:PHRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmadrug Inc (XCNQ:PHRX) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

LMLLF:USA G11:Germany

Address

77 King Street West, Suite 2905, Toronto, ON, CAN, M5K 1H1

Website

https://www.pharmadrug.ca

Pharmadrug Inc is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and naturally derived approved drugs. The Company's operations comprise of the corporate division in Canada. Geographically, it operates in Germany and Canada.

Pharmadrug (XCNQ:PHRX) Headlines

No Headlines